NDC 72237-102 – Xpovio
Selinexor 40 mg/1 · Tablet, Film Coated · Oral
Product NDC72237-102
Product details
- Brand name
- Xpovio
- Generic name
- Selinexor
- Labeler
- Karyopharm Therapeutics Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA212306
- Marketed since
- May 19, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nuclear Export Inhibitor
Active ingredients
- Selinexor 40 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 72237-102-02 | 4 BLISTER PACK in 1 CARTON (72237-102-02) / 2 TABLET, FILM COATED in 1 BLISTER PACK (72237-102-12) | May 19, 2021 |
| 72237-102-06 | 4 BLISTER PACK in 1 CARTON (72237-102-06) / 2 TABLET, FILM COATED in 1 BLISTER PACK (72237-102-16) | May 19, 2021 |
| 72237-102-07 | 4 BLISTER PACK in 1 CARTON (72237-102-07) / 1 TABLET, FILM COATED in 1 BLISTER PACK (72237-102-17) | May 19, 2021 |
Other Xpovio products
- 72237-101 Selinexor 20 mg/1 · Tablet, Film Coated · Karyopharm Therapeutics Inc.
- 72237-103 Selinexor 50 mg/1 · Tablet, Film Coated · Karyopharm Therapeutics Inc.
- 72237-104 Selinexor 60 mg/1 · Tablet, Film Coated · Karyopharm Therapeutics Inc.
- 72237-105 Selinexor 80 mg/1 · Tablet, Film Coated · Karyopharm Therapeutics Inc.
- 72237-106 Selinexor 10 mg/1 · Tablet, Film Coated · Karyopharm Therapeutics Inc.